Hut 8 Corp
F:V71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hut 8 Corp
F:V71
|
US |
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
KR |
|
E
|
E for L Aim PCL
SET:EFORL
|
TH |
|
L
|
LPS Brasil Consultoria de Imoveis SA
BOVESPA:LPSB3
|
BR |
|
B
|
Bannari Amman Spinning Mills Ltd
NSE:BASML
|
IN |
|
Daifuku Co Ltd
TSE:6383
|
JP |
|
Xinxiang Chemical Fiber Co Ltd
SZSE:000949
|
CN |
|
D
|
Dongwu Cement International Ltd
HKEX:695
|
CN |
|
C
|
Coraza Integrated Technology Bhd
KLSE:CORAZA
|
MY |
|
Shenzhen Aisidi Co Ltd
SZSE:002416
|
CN |
|
Zuming Bean Products Co Ltd
SZSE:003030
|
CN |
|
Hyakujushi Bank Ltd
TSE:8386
|
JP |
|
S
|
StableX Technologies Inc
NASDAQ:SBLX
|
US |
|
S
|
Sterling Bancorp
F:PVDA
|
US |
|
N
|
Newonder Special Electric Co Ltd
SZSE:301120
|
CN |
|
Pansoft Co Ltd
SZSE:300996
|
CN |
Balance Sheet
Balance Sheet Decomposition
Hut 8 Corp
Hut 8 Corp
Balance Sheet
Hut 8 Corp
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
4
|
3
|
3
|
140
|
31
|
|
| Cash |
0
|
4
|
3
|
3
|
140
|
31
|
|
| Short-Term Investments |
0
|
0
|
11
|
102
|
324
|
204
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
3
|
10
|
|
| Total Current Assets |
0
|
4
|
15
|
105
|
468
|
246
|
|
| PP&E Net |
0
|
58
|
35
|
33
|
96
|
125
|
|
| PP&E Gross |
0
|
58
|
35
|
33
|
96
|
125
|
|
| Accumulated Depreciation |
0
|
47
|
80
|
102
|
125
|
333
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
12
|
|
| Long-Term Investments |
0
|
15
|
16
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
6
|
6
|
7
|
157
|
27
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
12
|
|
| Total Assets |
0
N/A
|
83
+27 533%
|
71
-14%
|
145
+104%
|
721
+396%
|
413
-43%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
17
|
1
|
4
|
7
|
6
|
|
| Accrued Liabilities |
0
|
1
|
1
|
0
|
3
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
4
|
6
|
26
|
17
|
16
|
|
| Other Current Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
22
|
9
|
30
|
26
|
30
|
|
| Long-Term Debt |
0
|
28
|
20
|
0
|
24
|
31
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
6
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
99
|
0
|
|
| Total Liabilities |
0
N/A
|
50
+16 633%
|
29
-43%
|
30
+4%
|
155
+423%
|
62
-60%
|
|
| Equity | |||||||
| Common Stock |
1
|
163
|
171
|
178
|
637
|
768
|
|
| Retained Earnings |
1
|
135
|
133
|
113
|
186
|
429
|
|
| Additional Paid In Capital |
0
|
5
|
5
|
5
|
12
|
13
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
46
|
104
|
0
|
|
| Total Equity |
0
N/A
|
33
N/A
|
43
+31%
|
116
+171%
|
566
+390%
|
351
-38%
|
|
| Total Liabilities & Equity |
0
N/A
|
83
+27 533%
|
71
-14%
|
145
+104%
|
721
+396%
|
413
-43%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
0
|
85
|
90
|
97
|
170
|
221
|
|